Latest Breaking News On - Decipher biosciences - Page 1 : comparemela.com

Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results

Grew Fourth Quarter Revenue to $98.2 million Increased 2023 Total Revenue 22% to $361.1 million Conference Call and Webcast Today at 4:30 p.m. ET .

United statesMarc stapleyCompany formNational comprehensive cancer networkVeracyte incExchange commissionGenomics incVeracyte diagnostics platformDecipher prostatePercepta nasal swabRegarding useAnnual reportQuarterly reportDecipher biosciencesMonths ended decemberStockholder equity

Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results

Veracyte, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2023. "We closed 2023 with another quarter of excellent results, driven by our Afirma and Decipher businesses," said Marc Stapley, Veracyte's.

United statesMarc stapleyGenomics incCompany formVeracyte incExchange commissionNational comprehensive cancer networkConference callAnnounces fourth quarterVeracyte diagnostics platformDecipher prostatePercepta nasal swabRegarding useAnnual reportQuarterly reportDecipher biosciences

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.

Crizzystudio shutterstockAventa fusionplusChris robertsAventa genomicsfebKittyfly shutterstockCaris life sciencesSponsored contentExecutive directorAventa genomicsArima genomicsProtean biodiagnosticsImage creditCorporate strategyDecipher biosciencesVentana medical systemsNa sequencing

JPM24: Veracyte inks $95M deal to buy fellow cancer testing company C2i Genomics

JPM24: Veracyte inks $95M deal to buy fellow cancer testing company C2i Genomics
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Marc stapleyHealthcare conferenceSan francisco basedDecipher biosciences

Veracyte Announces Third Quarter 2023 Financial Results

Grew Total Revenue to $90.1 million, an Increase of 19% Grew Testing Revenue by 27% Conference Call and Webcast Today at 4:30 p.m. ET .

Phil febboMarc stapleyVeracyte incAmerican society for radiation oncologyExchange commissionCompany formDecipher prostateAmerican societyRadiation oncologyDecipher prostate genomic classifierDecipher genomic resourceIntelligent discoveryMarie claire taineCounter analysis systemRegarding useAnnual report